Importance of the correct assessment of bone fractures in the clinical management of metastatic castration-resistant prostate cancer treated with radium-223: A case report

Patients who undergo radium-223 treatment for metastatic castration-resistant prostate cancer (mCRPC) generally have a long history of androgen deprivation therapy and/or steroid therapy, which leads to bone loss and causes osteoporosis. Notably, Osteoporosis in combination with metastatic bone dise...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Mol Clin Oncol
Autors principals: Rizzini, Elisa Lodi, Ghedini, Pietro, Cardano, Raffaele, Bellarosa, Chiara, Morganti, Alessio Giuseppe, Fanti, Stefano, Monari, Fabio
Format: Artigo
Idioma:Inglês
Publicat: D.A. Spandidos 2019
Matèries:
Articles
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC6535633/
https://ncbi.nlm.nih.gov/pubmed/31289680
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3892/mco.2019.1852
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars